MedTechIndexBETA
The MedTechIndex Briefing

Keep up with MedTechIndex.

A weekly note from Blair, new companies added to the directory, and meaningful updates to existing profiles.

Confirm your email to join. Email privacy

Companies / CurvaFix
Medical device company profile

CurvaFix

Washington medical device manufacturer developing curved intramedullary implants for pelvic fracture fixation.

Medical Device ManufacturerOrthopedics & MusculoskeletalBone Repair & Reconstruction
Headquarters🇺🇸Kirkland, Washington, United States
Founded2013
Commercial statusCommercially availableCurvaFix Low Profile System commercially available in the United States.
Employees11–50 [4]LinkedIn company-size range · Checked 2026-11-02
Estimated revenueNot confirmed
Disclosed funding$39 million [3]Closed financing led by MVM Partners with participation from Sectoral Asset Management and existing investors.
Official websitecurvafix.com ↗

Company overview

CurvaFix is a Washington medical device company focused on fixation of fractures in the curved bones of the pelvis. Its current corporate website lists an office in Kirkland, Washington.

The CurvaFix Low Profile System uses flexible implants that follow pelvic anatomy during insertion and can then be locked into a rigid configuration. The system includes 7.5 mm and 9.5 mm implants, washers and associated instruments.

The company markets its technology in the United States. Mark Foster became president and CEO in 2023, when CurvaFix announced a $39 million equity financing led by MVM Partners.

[1][2][3][4][12]

Leadership

6 people
Mark FosterPresident and CEO [2][11]
Jeffrey PooleChief Financial Officer [2]
Tim ScottVice President of Sales and Commercial Development [2]
Nicole CarleoVice President, Marketing [2]
Carly ThalerVice President, Research and Development [2]
Olen ChiddixVice President, Operations [2]

Products & regulatory status How does MedTechIndex get this information?

Summary

CurvaFix’s scoped FDA snapshot documents 1 510(k) clearance. The latest dated decision in those reviewed records is K252019 (2025-08-29). [8]

Regulatory snapshot How to read this snapshot

U.S. FDA
1
510(k) clearances
—
De Novo grants
—
PMA approvals
—
Recall events

Latest recorded source review: 2026-11-02.

Scope: selected product families.

Commercial portfolio snapshot

Documented commercial product families.

CurvaFix Low Profile implant manufacturer illustration
Image: Manufacturer product image

CurvaFix Low Profile System ↗

Curved intramedullary pelvic fixation implants available in 7.5 mm and 9.5 mm diameters. The implant is flexible during insertion and uses an integral locking mechanism to become rigid after placement. [1][6]

Commercially available · U.S. 510(k) cleared

Commercially available · U.S. 510(k) cleared

Activity & Milestones

3 events
2025-08-29 · Regulatory

Low Profile System FDA clearance

FDA cleared the CurvaFix Low Profile System under K252019. [8]

2023-07-14 · Funding

$39 million Series C and CEO appointment

CurvaFix announced a closed equity financing led by MVM and named Mark Foster CEO. [3]

2019-03-01 · Regulatory

Initial CurvaFix Intramedullary Rodscrew System clearance

FDA cleared K180050 for pelvic fracture fixation. [10]

12 Cited Sources

Accessed 11/02/2026

Last substantive review: 11/2/2026

[2] Company leadership ↗CurvaFix · manufacturer
[4] CurvaFix company profile ↗CurvaFix via LinkedIn · company profile
[5] News and media coverage ↗CurvaFix · manufacturer
[7] Contact CurvaFix ↗CurvaFix · manufacturer
[8] FDA 510(k) K252019 ↗U.S. FDA · regulator
[9] FDA 510(k) K222505 ↗U.S. FDA · regulator
[10] FDA 510(k) K180050 ↗U.S. FDA · regulator
[12] CurvaFix corporate logo — company-issued press-release attachment ↗CurvaFix via GlobeNewswire · manufacturer · Published 2020-07-21
Company research

Compare companies

Privacy choices

Your saved-company and comparison preferences are stored separately. Changing analytics preferences does not clear them.

About cookies and privacy